The companies Eikon Therapeutics, Sionna Therapeutics, and Abcuro bagged the biggest biotech funding rounds overall in ...
a pre-commercial phase but expects to execute a final investment decision for its AlphaOne plant in March 2025 for start-up in 2026. The company will begin ...
Its licensing agreement with Australian startup AdvanCell was revealed two weeks ago. Leveraging AdvanCell’s Pb-212 production technology and radionuclide development infrastructure and Eli Lilly’s ...
bluebird stockholders to receive $3.00 per share in cash and a contingent value right of $6.84 per share in cash payable upon achievement of a net sales milestone, contingent upon offer conditions ...
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 million Series C financing.
MUNICH, Germany, and BASILDON, UK I February 13, 2025 I LINDIS Biotech GmbH, a clinical stage biopharmaceutical company with a proprietary multi-specific antibody platform and an advanced development ...
Johnson Winter Slattery (JWS) has assisted three of the lead investors in AdvanCell’s US$112m Series C financing effort. The firm worked with SV Health Investors, Sanofi Ventures and Abingworth on the ...
Prostate Cancer Real World Evidence Registry (PROCARE): Recurrent and metastatic prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract ...
Brisbane-based AdvanCell raised $178 million in one of the biggest funding rounds of 2025 so far. It's good news for an overlooked corner of the startup sector. AdvanceCell CEO Andrew Adamovich and ...
Parliament has passed the Scam Prevention Framework bill, a first-of-its-kind legislation aimed at curbing financial scams and enhancing protections across key industries. The bill establishes ...
Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology ...